"AstraZeneca PLC (AZN) Stock Performance: Key Insights for Investors"

AstraZeneca (AZN) has been trending on Zacks.com, prompting a closer look at factors influencing its performance. Earnings estimate revisions and revenue growth forecasts are key indicators, with the company expected to post earnings of $0.85 per share for the current quarter. The Zacks Rank #3 (Hold) suggests potential in line with the broader market, while valuation metrics indicate the stock is trading at a discount to its peers.